Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H17ClFN5O3S |
InChIKeyWKPVFIKSRZVXOX-UHFFFAOYSA-N |
CAS Registry1424871-27-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Phase 1 | Germany | - | |
| Neoplasms | Phase 1 | - | - |





